Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03192 |
| Species: | Homo sapiens |
| Position : | chr19:55417234-55417304 |
| Year: | 2012 |
| Title: | Role of runt-related transcription factor 3 (RUNX3) in transcription regulation of natural cytotoxicity receptor 1 (NCR1/NKp46), an activating natural killer (NK) cell receptor. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 22253448 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | NK-92 |
| CVCL ID: | CVCL_2142 |
| Cell Type: | natural killer cell |
| Cell Ontology ID: | CL:0000623 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay; Chromatin-state assay |
| Low Throughput Method: | Luciferase reporter assay; RUNX-site mutagenesis; EMSA; ChIP-qPCR; RUNX3 overexpression; dominant-negative RUNX perturbation; RT-qPCR; RT-PCR; Western blot; histone ChIP-qPCR |
| Target gene : | NCR1 |
| TF name : | RUNX3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| RUNX3 | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| RUNX3 | TGF_beta_Receptor | netpath | 220 |
| RUNX3 | Hs_TYROBP_Causal_Network_WP3945_90843 | wikipathways | 54 |
| RUNX3 | Hs_Sudden_Infant_Death_Syndrome_(SIDS)_Susceptibility_Pathways_WP706_86078 | wikipathways | 33 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03226 | chr19:55417234-55417304 | blood | natural killer cell | NA |